ST HULUWA has obtained the drug registration certificate for Cefdinir Capsules
I'm PortAI, I can summarize articles.
ST HULUWA recently obtained the drug registration certificate for Cefdinir capsules approved by the National Medical Products Administration. Cefdinir is a third-generation broad-spectrum cephalosporin, suitable for infections caused by various bacteria, including pharyngitis, pneumonia, and otitis media. The approval of this drug meets the technical requirements for the consistency evaluation of quality and efficacy of generic drugs
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments